Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Impact of Cerebral Oxygen Saturation Monitoring on Short-term Neurodevelopmental Outcomes in Neonates with Encephalopathy - A Prospective Cohort Study

Author(s): Vishal Vishnu Tewari*, Ashutosh Kumar, Arjun Kurup, Hitesh Daryani and Apoorv Saxena

Volume 18, Issue 4, 2022

Published on: 01 April, 2022

Page: [301 - 317] Pages: 17

DOI: 10.2174/1573396318666220304210653

Price: $65

Abstract

Background: Near-infrared spectroscopy (NIRS) has been used for monitoring cerebral oxygen saturation (rSO2) in neonates. There is a lack of data from low-middle income countries (LMIC) setting of cerebral rSO2 in neonates with encephalopathy of diverse etiologies. This study aimed to monitor cerebral rSO2 using NIRS in encephalopathic neonates to maintain the rSO2 between 55 to 85 % in the first 72 hours of admission to improve short-term neurodevelopmental outcomes (NDO).

Materials and Methods: This prospective cohort study enrolled encephalopathic neonates with hypoxic- ischemic encephalopathy (HIE) and non-HIE etiologies into 8 clinical categories. The cerebral rSO2 was monitored and targeted to be between 55 to 85 %, with predefined actions and management alterations over 72 hours. The neurodevelopmental assessment was conducted at 3, 6, and 9-12 months corrected age. Moreover, the motor and mental developmental quotients (MoDQ) (MeDQ) were recorded and compared to historical control.

Results: A total of 120 neonates were enrolled and assessed for NDO. The MoDQ (mean ± SD) was 92.55 ± 14.85, 93.80 ± 13.20, 91.02 ± 12.69 and MeDQ (mean ± SD) was 91.80 ± 12.98, 91.80 ± 13.69, 88.41 ± 11.60 at 3, 6 and 9-12 months. The MoDQ and MeDQ scores of the historic cohort at 12 months were 86.35 ± 20.34 and 86.58 ± 18.27. The mean difference [MD (95 %CI)] for MoDQ was - 4.670 (- 8.48 to - 0.85) (p=0.0165) and for MeDQ was - 1.83 (- 5.26 to 1.6) (p=0.29). There was a negative correlation between the composite developmental quotient (CoDQ) with mean rSO2 and a positive correlation with cerebral fractional tissue oxygen extraction (CFTOE). Neonates with HIE and neonatal encephalopathy (NE) (n=37/120) had the lowest motor and mental DQ on neurodevelopmental assessment. Clinical categories, neonatal meningitis (NM), and intraventricular hemorrhage (IVH) improved in DQ scores over the study period.

Conclusion: Monitoring and maintaining cerebral rSO2 between 55-85 % through appropriate management changes improved neurodevelopmental scores at the 12-month follow-up in neonates with encephalopathy caused by varied etiologies.

Keywords: Cerebral oxygenation, CFTOE, cerebral rSO2, near-infrared spectroscopy, neonatal encephalopathy, neurodevelopmental outcomes.

« Previous Next »
[1]
Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists’ Task Force on neonatal encephalopathy. Obstet Gynaecol 2014; 123: 896-901.
[2]
Martinello K, Hart AR, Yap S, Mitra S, Robertson NJ. Management and investigation of neonatal encephalopathy: 2017 update. Arch Dis Child Fetal Neonatal Ed 2017; 102(4): F346-58.
[http://dx.doi.org/10.1136/archdischild-2015-309639] [PMID: 28389438]
[3]
Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86(6): 329-38.
[http://dx.doi.org/10.1016/j.earlhumdev.2010.05.010] [PMID: 20554402]
[4]
McIntyre S, Nelson KB, Mulkey SB, Lechpammer M, Molloy E, Badawi N. Newborn Brain Society Guidelines and Publications Committee. Neonatal encephalopathy: Focus on epidemiology and underexplored aspects of etiology. Semin Fetal Neonatal Med 2021; 26(4): 101265.
[http://dx.doi.org/10.1016/j.siny.2021.101265] [PMID: 34305025]
[5]
Lee AC, Kozuki N, Blencowe H, et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res 2013; 74(Suppl. 1): 50-72.
[http://dx.doi.org/10.1038/pr.2013.206] [PMID: 24366463]
[6]
Van Meurs KP, Yan ES, Randall KS, et al. Development of a Neuro NICU with a broader focus on all newborns at risk of brain injury: The first 2 years. Am J Perinatol 2018; 35(12): 1197-205.
[http://dx.doi.org/10.1055/s-0038-1646954] [PMID: 29702712]
[7]
Liao SM, Culver JP. Near infrared optical technologies to illuminate the status of the neonatal brain. Curr Pediatr Rev 2014; 10(1): 73-86.
[http://dx.doi.org/10.2174/157339631001140408121507] [PMID: 25055866]
[8]
Gervain J, Mehler J, Werker JF, et al. Near-infrared spectroscopy: a report from the McDonnell infant methodology consortium. Dev Cogn Neurosci 2011; 1(1): 22-46.
[http://dx.doi.org/10.1016/j.dcn.2010.07.004] [PMID: 22436417]
[9]
Hyttel-Sorensen S, Pellicer A, Alderliesten T, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ 2015; 350: g7635.
[http://dx.doi.org/10.1136/bmj.g7635] [PMID: 25569128]
[10]
Pichler G, Urlesberger B, Baik N, et al. Cerebral oxygen saturation to guide oxygen delivery in preterm neonates for the immediate transition after birth: A 2-center randomized controlled pilot feasibility trial. J Pediatr 2016; (170): 73-8.e1. , 4.
[http://dx.doi.org/10.1016/j.jpeds.2015.11.053] [PMID: 26743498]
[11]
Eriksen VR, Hahn GH, Greisen G. Cerebral autoregulation in the preterm newborn using near-infrared spectroscopy: a comparison of time-domain and frequency-domain analyses. J Biomed Opt 2015; 20(3): 037009.
[http://dx.doi.org/10.1117/1.JBO.20.3.037009] [PMID: 25806662]
[12]
Peng S, Boudes E, Tan X, Saint-Martin C, Shevell M, Wintermark P. Does near-infrared spectroscopy identify asphyxiated newborns at risk of developing brain injury during hypothermia treatment? Am J Perinatol 2015; 32(6): 555-64.
[http://dx.doi.org/10.1055/s-0034-1396692] [PMID: 25594221]
[13]
Modi M, Saluja S, Kler N, et al. Growth and neurodevelopmental outcome of VLBW infants at 1 year corrected age. Indian Pediatr 2013; 50(6): 573-7.
[http://dx.doi.org/10.1007/s13312-013-0170-5] [PMID: 23255692]
[14]
Mukhopadhyay K, Malhi P, Mahajan R, Narang A. Neurodevelopmental and behavioral outcome of very low birth weight babies at corrected age of 2 years. Indian J Pediatr 2010; 77(9): 963-7.
[http://dx.doi.org/10.1007/s12098-010-0149-3] [PMID: 20814839]
[15]
Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292(19): 2357-65.
[http://dx.doi.org/10.1001/jama.292.19.2357] [PMID: 15547163]
[16]
Doctor BA, Newman N, Minich NM, Taylor HG, Fanaroff AA, Hack M. Clinical outcomes of neonatal meningitis in very-low birth-weight infants. Clin Pediatr (Phila) 2001; 40(9): 473-80.
[http://dx.doi.org/10.1177/000992280104000901] [PMID: 11583045]
[17]
Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008; 122(1): 65-74.
[http://dx.doi.org/10.1542/peds.2007-2822] [PMID: 18595988]
[18]
Szakmar E, Kovacs K, Meder U, et al. Neonatal encephalopathy therapy optimization for better neuroprotection with inhalation of CO2: the HENRIC feasibility and safety trial. Pediatr Res 2020; 87(6): 1025-32.
[http://dx.doi.org/10.1038/s41390-019-0697-9] [PMID: 31785594]
[19]
Finder M, Boylan GB, Twomey D, Ahearne C, Murray DM, Hallberg B. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia. JAMA Pediatr 2020; 174(1): 48-55.
[http://dx.doi.org/10.1001/jamapediatrics.2019.4011] [PMID: 31710357]
[20]
Mukerji A, Shah V, Shah PS. Periventricular/intraventricular hemorrhage and neurodevelopmental outcomes: A meta-analysis. Pediatrics 2015; 136(6): 1132-43.
[http://dx.doi.org/10.1542/peds.2015-0944] [PMID: 26598455]
[21]
Aldecoa-Bilbao V, García-Catalán MJ, Gaixa M, Clotet CJ, Teodoro S, Figaró VC. Neurodevelopmental impairment at two years in prema-ture infants with prolonged patency of ductus arteriosus after a conservative approach. Am J Perinatol 2019; 38(5): 449-55.
[http://dx.doi.org/10.1055/s-0039-1697674] [PMID: 31600790]
[22]
Oncel MY, Eras Z, Uras N, Canpolat FE, Erdeve O, Oguz SS. Neurodevelopmental outcomes of preterm infants treated with oral parace-tamol versus ibuprofen for patent ductus arteriosus. Am J Perinatol 2017; 34(12): 1185-9.
[http://dx.doi.org/10.1055/s-0037-1601564] [PMID: 28395364]
[23]
Bailey SM, Hendricks-Munoz KD, Mally P. Cerebral, renal, and splanchnic tissue oxygen saturation values in healthy term newborns. Am J Perinatol 2014; 31(4): 339-44.
[http://dx.doi.org/10.1055/s-0033-1349894] [PMID: 23873114]
[24]
Tan JKG, Minutillo C, McMichael J, Rao S. Impact of hypoglycaemia on neurodevelopmental outcomes in hypoxic ischaemic encephalopathy: A retrospective cohort study. BMJ Paediatr Open 2017; 1(1): e000175.
[http://dx.doi.org/10.1136/bmjpo-2017-000175] [PMID: 29637170]
[25]
Kenosi M, O’Toole JM, Hawkes GA, et al. Monitoring cerebral oxygenation of preterm infants using a neonatal specific sensor. J Perinatol 2018; 38(3): 264-70.
[http://dx.doi.org/10.1038/s41372-017-0007-5] [PMID: 29242570]
[26]
Jain SV, Pagano L, Gillam-Krakauer M, Slaughter JC, Pruthi S, Engelhardt B. Cerebral regional oxygen saturation trends in infants with hypoxic-ischemic encephalopathy. Early Hum Dev 2017; 113: 55-61.
[http://dx.doi.org/10.1016/j.earlhumdev.2017.07.008] [PMID: 28772198]
[27]
Forman E, Breatnach CR, Ryan S, et al. Noninvasive continuous cardiac output and cerebral perfusion monitoring in term infants with neonatal encephalopathy: assessment of feasibility and reliability. Pediatr Res 2017; 82(5): 789-95.
[http://dx.doi.org/10.1038/pr.2017.154] [PMID: 28665923]
[28]
Gagnon MH, Wintermark P. Effect of persistent pulmonary hypertension on brain oxygenation in asphyxiated term newborns treated with hypothermia. J Matern Fetal Neonatal Med 2016; 29(13): 2049-55.
[http://dx.doi.org/10.3109/14767058.2015.1077221] [PMID: 27480206]
[29]
Schwarz CE, Preusche A, Wolf M, Poets CF, Franz AR. Prospective observational study on assessing the hemodynamic relevance of patent ductus arteriosus with frequency domain near-infrared spectroscopy. BMC Pediatr 2018; 18(1): 66.
[http://dx.doi.org/10.1186/s12887-018-1054-6] [PMID: 29452581]
[30]
Plomgaard AM, Alderliesten T, van Bel F, et al. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (Safe-BoosC II) in preterm infants during the first days of life. Acta Paediatr 2019; 108(2): 275-81.
[http://dx.doi.org/10.1111/apa.14463] [PMID: 29908039]

Rights & Permissions Print Cite
Article Metrics
20
1
© 2024 Bentham Science Publishers | Privacy Policy